Informações:
Falhas:
ID
13596
Descrição
Serotonergic Pharmacotherapy for Agitation of Dementia; ODM derived from: https://clinicaltrials.gov/show/NCT00009204
Link
https://clinicaltrials.gov/show/NCT00009204
Palavras-chave
Versões (1)
- 18/02/2016 18/02/2016 -
Transferido a
18 de fevereiro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Dementia NCT00009204
Eligibility Dementia NCT00009204
- StudyEvent: Eligibility
Similar models
Eligibility Dementia NCT00009204
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
dementia of the alzheimer type (ad), vascular dementia (vd), mixed (ad and vd) or dementia nos
Item
meets dsm-iv criteria for diagnosis of dementia of the alzheimer's type (ad), vascular dementia (vd), mixed (ad and vd) or dementia nos (not otherwise specified)
boolean
C0002395 (UMLS CUI [1])
C0011269 (UMLS CUI [2])
C3532942 (UMLS CUI [3])
C0497327 (UMLS CUI [4])
C0011269 (UMLS CUI [2])
C3532942 (UMLS CUI [3])
C0497327 (UMLS CUI [4])
psychosis or abnormal behaviour
Item
presents with psychosis or behavioral problems severe enough to endanger the patient's health, well-being or safety, as evidenced by a score of at least 3 (moderate) on one of the neurobehavioral rating scale (nbrs) agitation items (8,11,14) or psychosis items (16,18,20) and are not secondary to physical illness nor amenable to environmental optimization
boolean
C0033975 (UMLS CUI [1])
C0233514 (UMLS CUI [2])
C0233514 (UMLS CUI [2])
able to participate in study
Item
able to participate in study evaluations and ingest oral medication
boolean
C1321605 (UMLS CUI [1])
next of kin or a guardian available
Item
has next of kin or a guardian available to consent to patient's participation.
boolean
C1321605 (UMLS CUI [1])
unstable medical illness
Item
has an unstable medical illness including significant cardiac (specifically bradycardia with ventricular rate below 50), renal, hepatic, or neurological illness (especially parkinson's disease) other than dementia
boolean
C0009488 (UMLS CUI [1])
delirium
Item
meets dsm-iv criteria for delirium upon admission to western psychiatric institute and clinic
boolean
C0011206 (UMLS CUI [1])
fluoxetine or monoamine oxidase inhibitor treatment
Item
has been medicated within 4 weeks of protocol admission with fluoxetine or 2 weeks with a monoamine oxidase inhibitor (patients will undergo a monitored psychotropic drug washout prior to entering the protocol)
boolean
C0016365 (UMLS CUI [1])
C0026457 (UMLS CUI [2])
C0026457 (UMLS CUI [2])
cognitive enhancing drugs (tacrine or aricept) or any experimental drug
Item
is currently being treated with cognitive enhancing drugs (tacrine or aricept) or any experimental drug
boolean
C0039245 (UMLS CUI [1])
C0527315 (UMLS CUI [2])
C0304229 (UMLS CUI [3])
C0527315 (UMLS CUI [2])
C0304229 (UMLS CUI [3])
schizophrenia, bipolar disorder, or major depression
Item
has a concurrent diagnosis of schizophrenia, bipolar disorder, or major depression
boolean
C0005586 (UMLS CUI [1])
C1269683 (UMLS CUI [2])
C1269683 (UMLS CUI [2])
orthostatic hypotension
Item
has preexisting orthostatic hypotension (with > 20 mmhg change from sitting to standing pressure)
boolean
C0020651 (UMLS CUI [1])